Menu
1-702-720-6310 info@microcapspecualtors.com

Amgen, Biogen, Celgene Eye M&A In Trump’s ‘Pro-Biotech’ World – Investor’s Business Daily


Investor’s Business Daily

Amgen, Biogen, Celgene Eye M&A In Trump’s ‘Pro-Biotech‘ World
Investor’s Business Daily
Regardless, investors are starting to key in on the pro-biz environment. Since the election, shares of IBD’s 421-company Medical-Biomed/Biotech industry group and the SPDR S&P Biotech ETF (XBI) are nearly 15%. The iShares Nasdaq Biotech ETF (IBB) is …

Search